Luca Issi
Stock Analyst at RBC Capital
(0.46)
# 4,023
Out of 4,361 analysts
654
Total ratings
38.9%
Success rate
-2.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $445 | $286.12 | +55.53% | 62 | May 27, 2026 | |
| ARGX argenx SE | Maintained: Buy | $890 | $802.17 | +10.95% | 10 | May 27, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $700.60 | - | 1 | May 27, 2026 | |
| SGMO Sangamo Therapeutics, Inc. | Maintained: Hold | $2 | $0.214 | +834.58% | 21 | May 14, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $19 | $6.52 | +191.41% | 39 | May 14, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $9 | $2.05 | +339.02% | 32 | May 13, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Hold | $15 | $13.13 | +14.24% | 36 | May 11, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $30 | $17.24 | +74.01% | 11 | May 11, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $20 | $4.51 | +343.46% | 14 | May 11, 2026 | |
| KRRO Korro Bio | Maintained: Hold | $8 | $11.00 | -27.27% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $28.96 | -10.22% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.32 | +331.03% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $87 | $70.82 | +22.85% | 38 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $275 | $216.60 | +26.96% | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $63.88 | +56.54% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $21.78 | +60.70% | 18 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $26.76 | +30.79% | 42 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.82 | +41.84% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $66 | $53.32 | +23.78% | 35 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $52.02 | -3.88% | 29 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $38 | $45.64 | -16.74% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 | $328.26 | +12.72% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $100 | $72.97 | +37.04% | 39 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $26.51 | +5.62% | 6 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.69 | +163.62% | 27 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $3.14 | +218.47% | 5 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $10.17 | +37.66% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $9.24 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $12.64 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $7.13 | n/a | 7 | Mar 21, 2023 |
Alnylam Pharmaceuticals
May 27, 2026
Maintained: Buy
Price Target: $445
Current: $286.12
Upside: +55.53%
argenx SE
May 27, 2026
Maintained: Buy
Price Target: $890
Current: $802.17
Upside: +10.95%
argenx SE
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $700.60
Upside: -
Sangamo Therapeutics, Inc.
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.214
Upside: +834.58%
REGENXBIO
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $6.52
Upside: +191.41%
Allogene Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $2.05
Upside: +339.02%
Intellia Therapeutics
May 11, 2026
Maintained: Hold
Price Target: $15
Current: $13.13
Upside: +14.24%
Dyne Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $17.24
Upside: +74.01%
Lexeo Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $20
Current: $4.51
Upside: +343.46%
Korro Bio
May 8, 2026
Maintained: Hold
Price Target: $8
Current: $11.00
Upside: -27.27%
May 8, 2026
Maintained: Hold
Price Target: $26
Current: $28.96
Upside: -10.22%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $2.32
Upside: +331.03%
May 7, 2026
Maintained: Buy
Price Target: $80 → $87
Current: $70.82
Upside: +22.85%
May 7, 2026
Maintained: Buy
Price Target: $275
Current: $216.60
Upside: +26.96%
May 7, 2026
Maintained: Buy
Price Target: $100
Current: $63.88
Upside: +56.54%
May 5, 2026
Reiterated: Buy
Price Target: $35
Current: $21.78
Upside: +60.70%
May 5, 2026
Maintained: Buy
Price Target: $35
Current: $26.76
Upside: +30.79%
May 5, 2026
Maintained: Hold
Price Target: $4
Current: $2.82
Upside: +41.84%
May 4, 2026
Maintained: Hold
Price Target: $66
Current: $53.32
Upside: +23.78%
May 4, 2026
Maintained: Hold
Price Target: $50
Current: $52.02
Upside: -3.88%
May 1, 2026
Maintained: Hold
Price Target: $35 → $38
Current: $45.64
Upside: -16.74%
Apr 30, 2026
Maintained: Buy
Price Target: $370
Current: $328.26
Upside: +12.72%
Apr 29, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $72.97
Upside: +37.04%
Apr 29, 2026
Maintained: Hold
Price Target: $28
Current: $26.51
Upside: +5.62%
Apr 28, 2026
Maintained: Buy
Price Target: $15
Current: $5.69
Upside: +163.62%
Apr 27, 2026
Maintained: Hold
Price Target: $10
Current: $3.14
Upside: +218.47%
Mar 9, 2026
Rated: Buy
Price Target: $14
Current: $10.17
Upside: +37.66%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $9.24
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $12.64
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $7.13
Upside: n/a